Cash burn in Q3 2023 was approx $2m on minimal exploration activity.
$11m pump and dump CR (at 45c) in April, left many sophs less than happy, was depleted by another $2m in Q4 2023 5B, leaving cash $15m at 30th June, 2023. This became my entry point.
Q1 2024 5B due by end October, will most likely burn $3m+ and deplete residual cash to less than 4 quarters before next cap in hand becomes an imperative, particularly if scaling up drilling/resource activities.
I have no inside into the company, but have found there is rarely enough cash held by any explorer to meet ongoing exploration activities and G&A expenses incl. listing, accounts, audit fees. Thus a CR at any time, but particularly when a business is not on its knees, is nearly always a good idea.
I concede my sense of need could quite easily be wrong here, but the market seems to be unimpressed.
Experience has taught me most juniors conduct a CR after presenting a positive outlook. Do not get me wrong here, I remain confident in the potential business case in front of AR3. However, I am somewhat a realist that negative cash flows always need replenishing.
All will be revealed in due course, to eliminate or confirm my hunch.
- Forums
- ASX - By Stock
- AR3
- Ann: AR3 Corporate Presentation
AR3
australian rare earths limited
Add to My Watchlist
1.85%
!
5.5¢

Ann: AR3 Corporate Presentation, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.5¢ |
Change
0.001(1.85%) |
Mkt cap ! $11.65M |
Open | High | Low | Value | Volume |
5.5¢ | 5.5¢ | 5.2¢ | $21.64K | 402.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50057 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 46078 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50057 | 0.054 |
2 | 104634 | 0.053 |
4 | 258098 | 0.052 |
5 | 168607 | 0.051 |
8 | 288932 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 46078 | 4 |
0.056 | 119317 | 3 |
0.057 | 184524 | 1 |
0.058 | 50000 | 1 |
0.060 | 39292 | 2 |
Last trade - 13.59pm 27/06/2025 (20 minute delay) ? |
Featured News
AR3 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online